completed
Apr 4, 2023
A randomized, active-controlled, double-blind clinical study to investigate the safety and efficacy of oral Islatravir, a once-monthly pill as pre-exposure prophylaxis (PrEP) in cisgender women at high risk for HIV-1 infection. Closed to enrollment. In active study...
Apr 4, 2023
ICAP provided support and technical expertise to the national public health system in the following areas: Supported a national HIV drug resistance survey to assess prevalence and patterns of acquired drug resistance and pre-treatment drug resistance. Supported the...
Apr 4, 2023
ICAP, in partnership with CDC’s International Infection Control Program, is collaborating with the Ministry of Health in Tanzania to launch a regional community of practice to rapidly enhance infection, prevention, and control (IPC) at scale. The goal is to reduce...
Apr 4, 2023
This project provides comprehensive, community-based HIV Prevention, Linkage and Retention Services for Key Populations and Adolescent Girls and Young Women in eight regions across Tanzania including Dar es Salaam, Pwani, Mwanza, Mara, Simiyu, Kigoma, Kagera and...
Apr 3, 2023
The OPTIMIZE project was dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries, including Zimbabwe. Learn More:...
